|Day's Range||0.0000 - 0.0000|
|52 Week Range|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Johnson & Johnson’s (JNJ) Medical Devices segment revenues decreased ~0.1% to ~$25.1 billion for 2016, compared to 2015.
Johnson & Johnson’s (JNJ) Medical Devices segment grew ~1.1% to ~$6.2 billion for 3Q16 compared to 3Q15.
U.S. authorities will reach a settlement with medical device maker Zimmer Biomet Holdings Inc over bribery allegations in the next four weeks, prosecutors said in a court filing Thursday. The new agreement would replace a 2012 settlement with the U.S. Justice Department over allegations that Biomet paid bribes to state-employed healthcare providers in Argentina, Brazil and China in order to win business. Prosecutors said in June that Biomet breached that agreement after the company came forward with new allegations of misconduct in Mexico and Brazil.